$MRBK
Meridian Corp Stock $mrbk

$mrbk Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000175073524000040 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$1.444M	$1.317M
YoY Change	-95.73%	-95.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	-$82.00K	$2.259M
YoY Change	-182.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$20.61M
YoY Change		55.28%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$4.392M	$3.553M
YoY Change	-25.58%	-30.7%
Income Tax	$1.066M	$877.0K
% Of Pretax Income	24.27%	24.68%
Net Earnings	$3.326M	$2.676M
YoY Change	-28.4%	-33.45%
Net Earnings / Revenue	230.33%	203.19%
Basic Earnings Per Share	$0.30	$0.24
Diluted Earnings Per Share	$0.30	$0.24
COMMON SHARES
Basic Shares Outstanding	11.19M shares	11.19M shares
Diluted Shares Outstanding	11.15M shares	11.20M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$24.06M	$23.03M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$13.11M	$13.45M
YoY Change	-0.91%	1.28%
Goodwill	$899.0K	$899.0K
YoY Change	0.0%	0.0%
Intangibles	$2.869M	$2.920M
YoY Change	-6.64%	-6.53%
Long-Term Investments	$2.088M	$2.092M
YoY Change	-0.57%	-0.85%
Other Assets	$3.950M	$4.339M
YoY Change	-8.14%	8.02%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.352B	$2.293B
YoY Change	6.56%	2.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.709M	$8.350M
YoY Change	37.66%	117.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$143.0M	$112.1M
YoY Change	-21.55%	-49.38%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.709M	$154.2M
YoY Change	-96.15%	-35.15%
LONG-TERM LIABILITIES
Long-Term Debt	$237.2M	$49.87M
YoY Change	488.48%	23.68%
Other Long-Term Liabilities	$28.90M	$28.27M
YoY Change	-2.69%	-0.04%
Total Long-Term Liabilities	$266.1M	$78.14M
YoY Change	280.08%	13.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.709M	$154.2M
Total Long-Term Liabilities	$266.1M	$78.14M
Total Liabilities	$2.189B	$2.133B
YoY Change	6.64%	2.71%
SHAREHOLDERS EQUITY
Retained Earnings	$104.4M	$102.5M
YoY Change	5.01%	6.56%
Common Stock		$13.19M
YoY Change		0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$26.08M	$26.08M
YoY Change	0.0%	6.39%
Treasury Stock Shares
Shareholders Equity	$162.4M	$159.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.352B	$2.293B
YoY Change	6.56%	2.83%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$3.326M	$2.676M
YoY Change	-28.4%	-33.45%
Depreciation, Depletion And Amortization	-$82.00K	$2.259M
YoY Change	-182.0%
Cash From Operating Activities	-$19.21M	-$1.706M
YoY Change	19109.0%	-85.04%
INVESTING ACTIVITIES
Capital Expenditures	$54.00K	$1.910M
YoY Change	-82.0%	572.54%
Acquisitions
YoY Change
Other Investing Activities	-$34.55M	-$76.82M
YoY Change	11.1%	-8.46%
Cash From Investing Activities	-$34.61M	-$78.73M
YoY Change	10.21%	-6.5%
FINANCING ACTIVITIES
Cash Dividend Paid		$1.400M
YoY Change		-1.96%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	54.84M	$46.76M
YoY Change	-282.21%	-71.78%
NET CHANGE
Cash From Operating Activities	-19.21M	-$1.706M
Cash From Investing Activities	-34.61M	-$78.73M
Cash From Financing Activities	54.84M	$46.76M
Net Change In Cash	1.031M	-$33.67M
YoY Change	-101.67%	-148.02%
FREE CASH FLOW
Cash From Operating Activities	-$19.21M	-$1.706M
Capital Expenditures	$54.00K	$1.910M
Free Cash Flow	-$19.26M	-$3.616M
YoY Change	4715.75%	-69.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4021000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	13189000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	13186000	usd
CY2023Q1	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#InvestmentAdviceMember
CY2024Q1	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#InvestmentAdviceMember
CY2024Q1	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#InvestmentAdviceMember
CY2023Q1	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#InvestmentAdviceMember
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2024Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1251000	usd
CY2023Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	959000	usd
CY2024Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	325000	usd
CY2023Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	354000	usd
CY2024Q1	mrbk	Interest Income Cash And Cash Equivalents InterestIncomeCashAndCashEquivalents	300000	usd
CY2023Q1	mrbk	Interest Income Cash And Cash Equivalents InterestIncomeCashAndCashEquivalents	217000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37215000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	30947000	usd
CY2024Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	17392000	usd
CY2023Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	11447000	usd
CY2024Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	3214000	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1823000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	20606000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13270000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16609000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17677000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2866000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1399000	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	13743000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	16278000	usd
CY2024Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	3634000	usd
CY2023Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	3272000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1317000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1196000	usd
CY2024Q1	mrbk	Sba Income Net Amortization SbaIncomeNetAmortization	986000	usd
CY2023Q1	mrbk	Sba Income Net Amortization SbaIncomeNetAmortization	713000	usd
CY2024Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	207000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	192000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	75000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-69000	usd
CY2024Q1	mrbk	Loans Held For Sale Gain Loss On Change In Fair Value LoansHeldForSaleGainLossOnChangeInFairValue	-2000	usd
CY2023Q1	mrbk	Loans Held For Sale Gain Loss On Change In Fair Value LoansHeldForSaleGainLossOnChangeInFairValue	-1000	usd
CY2024Q1	mrbk	Increase Decrease In Loans Held For Investments IncreaseDecreaseInLoansHeldForInvestments	-175000	usd
CY2023Q1	mrbk	Increase Decrease In Loans Held For Investments IncreaseDecreaseInLoansHeldForInvestments	117000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-19000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2024Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1961000	usd
CY2023Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1218000	usd
CY2024Q1	us-gaap	Noninterest Income NoninterestIncome	7984000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	6638000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10573000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11061000	usd
CY2024Q1	us-gaap	Occupancy Net OccupancyNet	1233000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	1244000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	1498000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	823000	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	748000	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	861000	usd
CY2024Q1	mrbk	Data Processing And Software DataProcessingAndSoftware	1532000	usd
CY2023Q1	mrbk	Data Processing And Software DataProcessingAndSoftware	1432000	usd
CY2024Q1	mrbk	Pennsylvania Bank Shares Tax Expense PennsylvaniaBankSharesTaxExpense	274000	usd
CY2023Q1	mrbk	Pennsylvania Bank Shares Tax Expense PennsylvaniaBankSharesTaxExpense	245000	usd
CY2024Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2316000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2123000	usd
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	18174000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	17789000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3553000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5127000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	877000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1106000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2676000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4021000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11088000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11272000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11201000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11656000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2676000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-98000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-298000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1670000	usd
CY2024Q1	us-gaap	Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss Tax OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossTax	-7000	usd
CY2023Q1	us-gaap	Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss Tax OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax	22000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-90000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-276000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1670000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-247000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	749000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	473000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1670000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3149000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5691000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	158022000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2676000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	473000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1400000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	23000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	142000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159936000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	153280000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1670000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1428000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	184598	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2691000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	148000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	277000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	153049000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	2676000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4021000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-240000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-373000	usd
CY2024Q1	mrbk	Depreciation And Amortization Including Amortization Of Loan Fees DepreciationAndAmortizationIncludingAmortizationOfLoanFees	1780000	usd
CY2023Q1	mrbk	Depreciation And Amortization Including Amortization Of Loan Fees DepreciationAndAmortizationIncludingAmortizationOfLoanFees	-2000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2866000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1399000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	31000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	27000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	142000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	277000	usd
CY2024Q1	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	75000	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	-69000	usd
CY2024Q1	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	-2000	usd
CY2023Q1	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	-1000	usd
CY2024Q1	mrbk	Increase Decrease In Loans Held For Investment IncreaseDecreaseInLoansHeldForInvestment	-175000	usd
CY2023Q1	mrbk	Increase Decrease In Loans Held For Investment IncreaseDecreaseInLoansHeldForInvestment	117000	usd
CY2024Q1	mrbk	Amortization Of Mortgage Servicing Rights Ms Rs And Net Impairment Of Servicing Rights AmortizationOfMortgageServicingRightsMSRsAndNetImpairmentOfServicingRights	479000	usd
CY2023Q1	mrbk	Amortization Of Mortgage Servicing Rights Ms Rs And Net Impairment Of Servicing Rights AmortizationOfMortgageServicingRightsMSRsAndNetImpairmentOfServicingRights	435000	usd
CY2024Q1	mrbk	Sba Income SbaIncome	986000	usd
CY2023Q1	mrbk	Sba Income SbaIncome	713000	usd
CY2024Q1	mrbk	Proceeds From Sales Of Loans ProceedsFromSalesOfLoans	143457000	usd
CY2023Q1	mrbk	Proceeds From Sales Of Loans ProceedsFromSalesOfLoans	136837000	usd
CY2024Q1	mrbk	Payments For Loans Originated For Sale PaymentsForLoansOriginatedForSale	144437000	usd
CY2023Q1	mrbk	Payments For Loans Originated For Sale PaymentsForLoansOriginatedForSale	147238000	usd
CY2024Q1	mrbk	Mortgage Banking Income MortgageBankingIncome	3634000	usd
CY2023Q1	mrbk	Mortgage Banking Income MortgageBankingIncome	3272000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	539000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	288000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	353000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1607000	usd
CY2024Q1	mrbk	Gain Loss From Investment In Life Insurance GainLossFromInvestmentInLifeInsurance	207000	usd
CY2023Q1	mrbk	Gain Loss From Investment In Life Insurance GainLossFromInvestmentInLifeInsurance	192000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-251000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-54000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1974000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1447000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1098000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2803000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1706000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11400000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3554000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2222000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	9068000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	10702000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	554000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	865000	usd
CY2024Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	488000	usd
CY2023Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	3242000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	71370000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	73057000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1910000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	284000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-78728000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84198000	usd
CY2024Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	77234000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	57934000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months ProceedsFromRepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	-29093000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months ProceedsFromRepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	108368000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	3433000	usd
CY2024Q1	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	54000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2691000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1400000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1428000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	23000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	148000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	46764000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	165710000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33670000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	70112000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56697000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38391000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23027000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108503000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	22580000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	11823000	usd
CY2024Q1	mrbk	Noncash Or Partial Noncash Net Loan Assets Sold NoncashOrPartialNoncashNetLoanAssetsSold	10631000	usd
CY2023Q1	mrbk	Noncash Or Partial Noncash Net Loan Assets Sold NoncashOrPartialNoncashNetLoanAssetsSold	0	usd
CY2024Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporation’s unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management, all adjustments necessary for a fair presentation of the consolidated financial position and the results of operations for the interim periods presented have been included.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Amounts subject to significant estimates are items such as the allowance for credit losses, lending related commitments and the related unfunded commitment reserve, the fair value of financial instruments, other-than-temporary impairments of investment securities, and the valuations of goodwill, intangible assets, and servicing assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These unaudited consolidated financial statements should be read in conjunction with the Corporation’s filings with the SEC (including our Annual Report on Form 10-K for the year ended December 31, 2023), subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K that update or provide information in addition to the information included in Form 10-K and Form 10-Q filings, if any.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with current period presentation. Reclassifications had no effect on net income or stockholders’ equity. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results for the year ending December 31, 2024 or for any other period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Split</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 28, 2023, the Corporation approved and declared a two-for-one stock split in the form of a stock dividend, paid March 20, 2023, to shareholders of record as of March 14, 2023. Under the terms of the stock split, the Corporation’s shareholders received a dividend of one share for every share held on the record date. The dividend was paid in authorized but unissued shares of common stock of the Corporation. The par value of the Corporation's stock was not affected by the split and remained at $1.00 per share. All share and per share amounts reported in the consolidated financial statements have been adjusted to reflect the two-for-one stock split.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pronouncements Adopted in 2024</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2020-06, “Debt With Conversion </span><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”</span></div><div style="text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This ASU clarifies the accounting for certain financial instruments with characteristics of liabilities and equity. The amendments in this update reduce the number of accounting models for convertible debt instruments and convertible preferred stock by removing the cash conversion model and the beneficial conversion feature models.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For public business entities that meet the definition of an SEC filer (excluding smaller reporting entities), the amendments are effective for fiscal years beginning after Dec. 15, 2021, and interim periods within. For all other entities, the amendments are effective for fiscal years beginning after Dec. 15, 2023, and interim periods within. Adoption of this standard did not have a material impact on our consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2023-02, "Investments Equity Method and Joint Ventures (Topic 323) Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method"</span></div><div style="text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2023, the FASB issued ASU 2023-02, Investments Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method to allow reporting entities to consistently account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. If certain conditions are met, a reporting entity may elect to account for its tax equity investments by using the proportional amortization method regardless of the program from which it receives income tax credits, instead of only LIHTC structures. This amendment also eliminates certain LIHTC specific guidance aligning the accounting with other equity investments in tax credit structures. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Adoption of this standard did not have a material effect on our consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pronouncements Not Yet Effective as of March 31, 2024:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2020-04 (Topic 848), “Reference Rate Reform (“ASC 848”): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued in March 2020, ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The Corporation does not have a significant concentration of loans, derivative contracts, borrowings or other financial instruments with attributes that are either directly or indirectly dependent on LIBOR. The Corporation expects to adopt the LIBOR transition relief allowed under this standard throughout 2024.</span></div><div style="text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2023-07, “Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures”</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amendments in this update improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. The amendments in this update also do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Corporation is currently evaluating the impact on its results of operation, financial position, liquidity, and disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2023-09, “Income Taxes (Topic 740) Improvements to Income Tax Disclosures”</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in this update are effective for fiscal years beginning after December 15, 2024 and are to be applied on a prospective basis. Early adoption is permitted.The Corporation is currently evaluating the impact on its disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FASB ASU 2024-01 Stock Compensation - Scope Application of Profits Interest and Similar Awards</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#211d1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amendments in this update improve the understandability of paragraph 718-10-15-3 apply to all entities that enter into share-based payments transactions. The amendments in this update are effective for fiscal years beginning after December 15, 2024 and are to be applied on a prospective basis. The Corporation is currently evaluating the impact on its disclosures.</span></div>
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2023Q1	mrbk	Stockholders Equity Note Stock Split.Stock Dividend Issued Per Security Held StockholdersEquityNoteStockSplit.StockDividendIssuedPerSecurityHeld	1
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2676000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4021000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	11245000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	11456000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	157000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	184000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11088000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11272000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	113000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	230000	shares
CY2024Q1	mrbk	Incremental Common Shares Attributable To Dilutive Effect Of Retirement Plan IncrementalCommonSharesAttributableToDilutiveEffectOfRetirementPlan	0	shares
CY2023Q1	mrbk	Incremental Common Shares Attributable To Dilutive Effect Of Retirement Plan IncrementalCommonSharesAttributableToDilutiveEffectOfRetirementPlan	154000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11201000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11656000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	585000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	463000	shares
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	161865000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	383000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11252000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	150996000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	133	security
CY2024Q1	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	35157000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	20000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	3174000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	32003000	usd
CY2024Q1	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	21	security
CY2024Q1	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	35157000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	20000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	3174000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	32003000	usd
CY2024Q1	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	21	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	156492000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	491000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10964000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	146019000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	133	security
CY2023Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	35781000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	52000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	3103000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	32730000	usd
CY2023Q4	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	21	security
CY2024Q1	mrbk	Debt Securities Other Than Temporary Impairment Number Of Positions DebtSecuritiesOtherThanTemporaryImpairmentNumberOfPositions	0	security
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	17564000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	267000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	110090000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10985000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	127654000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	11252000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1067000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	29631000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3172000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	30698000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	3174000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	14566000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	193000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	110242000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10771000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	124808000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	10964000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1021000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	29404000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3097000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	30425000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	3103000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	0	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	32983000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	30318000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	3334000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3212000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	16509000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	15036000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year5 Through10 DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYear5Through10	4337000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	3677000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	50887000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	47115000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year10 DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYear10	27486000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue	25114000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	100379000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	92469000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDate	35157000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	32003000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	61486000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	58527000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Without Single Maturity Date DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityWithoutSingleMaturityDate	0	usd
CY2024Q1	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	161865000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	150996000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	35157000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	32003000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess	1950036000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess	1888448000	usd
CY2024Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13139000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13726000	usd
CY2024Q1	mrbk	Loans Receivable Amortized Cost LoansReceivableAmortizedCost	15812000	usd
CY2023Q4	mrbk	Loans Receivable Amortized Cost LoansReceivableAmortizedCost	16198000	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	16083000	usd
CY2023Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	19210000	usd
CY2024Q1	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-6279000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-7358000	usd
CY2024Q1	mrbk	Financing Receivable Excluding Interest Total Accruing Loans And Leases FinancingReceivableExcludingInterestTotalAccruingLoansAndLeases	1911791000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	38245000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess	1950036000	usd
CY2024Q1	us-gaap	Financing Receivable Percent Past Due1 FinancingReceivablePercentPastDue1	0.0237
CY2024Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13100000	usd
CY2023Q4	mrbk	Financing Receivable Excluding Interest Total Accruing Loans And Leases FinancingReceivableExcludingInterestTotalAccruingLoansAndLeases	1854685000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	33763000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess	1888448000	usd
CY2023Q4	us-gaap	Financing Receivable Percent Past Due1 FinancingReceivablePercentPastDue1	0.0210
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13700000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance	16142000	usd
CY2024Q1	mrbk	Financing Receivable Excluding Accrued Interest Nonaccrual With Allowance FinancingReceivableExcludingAccruedInterestNonaccrualWithAllowance	22103000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	38245000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance	15860000	usd
CY2023Q4	mrbk	Financing Receivable Excluding Accrued Interest Nonaccrual With Allowance FinancingReceivableExcludingAccruedInterestNonaccrualWithAllowance	17903000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	33763000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	38245000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	33763000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	22107000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	2444000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	134000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	3374000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	23171000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	18828000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	1497000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	44000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1471000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20442000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	3374000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1471000	usd
CY2024Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-508000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-72000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2866000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1399000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	8463000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	14708000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	23171000	usd
CY2024Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	37474000	usd
CY2024Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1899423000	usd
CY2024Q1	mrbk	Financing Receivable Excluding Loans And Leases Carried At Fair Value FinancingReceivableExcludingLoansAndLeasesCarriedAtFairValue	1936897000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	6496000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	15611000	usd
CY2023Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	32977000	usd
CY2023Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1841745000	usd
CY2023Q4	mrbk	Financing Receivable Excluding Loans And Leases Carried At Fair Value FinancingReceivableExcludingLoansAndLeasesCarriedAtFairValue	1874722000	usd
CY2024Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13100000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	13700000	usd
CY2024Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	4	loan
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Modified Period FinancingReceivableExcludingAccruedInterestModifiedPeriod	1456000	usd
CY2024Q1	mrbk	Financing Receivable Excluding Accrued Interest Modified In Period Related Reserve Allowance FinancingReceivableExcludingAccruedInterestModifiedInPeriodRelatedReserveAllowance	0	usd
CY2024Q1	mrbk	Financing Receivable Nonaccrual Modifications Number Of Contracts FinancingReceivableNonaccrualModificationsNumberOfContracts	1	loan
CY2024Q1	mrbk	Financing Receivable Nonaccrual Excluding Accrued Interest Modified In Period Amount FinancingReceivableNonaccrualExcludingAccruedInterestModifiedInPeriodAmount	895000	usd
CY2024Q1	mrbk	Financing Receivable Nonaccrual Excluding Accrued Interest Modified In Period Related Reserve Allowance FinancingReceivableNonaccrualExcludingAccruedInterestModifiedInPeriodRelatedReserveAllowance	784000	usd
CY2024Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	4	loan
CY2024Q1	mrbk	Financing Receivable Modifications Accrual And Nonaccrual Loans Number Of Contracts FinancingReceivableModificationsAccrualAndNonaccrualLoansNumberOfContracts	5	modification
CY2023Q1	mrbk	Financing Receivable Modifications Accrual And Nonaccrual Loans Number Of Contracts FinancingReceivableModificationsAccrualAndNonaccrualLoansNumberOfContracts	0	modification
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	112131000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	141224000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16609000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17677000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2866000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1399000	usd
CY2023Q2	mrbk	Derivative Number Of Instruments Entered Into During The Period DerivativeNumberOfInstrumentsEnteredIntoDuringThePeriod	3	derivative_instrument
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	749000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2024Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	260114000	usd
CY2024Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	640000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	226652000	usd
CY2023Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-410000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1051000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-69000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-19000	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	13743000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	16278000	usd
CY2024Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	3634000	usd
CY2023Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	3272000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1317000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1196000	usd
CY2024Q1	mrbk	Sba Income Net Amortization SbaIncomeNetAmortization	986000	usd
CY2023Q1	mrbk	Sba Income Net Amortization SbaIncomeNetAmortization	713000	usd
CY2024Q1	mrbk	Gain Loss On Net Change In Fair Values GainLossOnNetChangeInFairValues	-102000	usd
CY2023Q1	mrbk	Gain Loss On Net Change In Fair Values GainLossOnNetChangeInFairValues	47000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-19000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2024Q1	mrbk	Noninterest Income Other Operating Income Miscellaneous NoninterestIncomeOtherOperatingIncomeMiscellaneous	2168000	usd
CY2023Q1	mrbk	Noninterest Income Other Operating Income Miscellaneous NoninterestIncomeOtherOperatingIncomeMiscellaneous	1410000	usd
CY2024Q1	us-gaap	Noninterest Income NoninterestIncome	7984000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	6638000	usd
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	18174000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	17789000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3553000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5127000	usd
CY2024Q1	us-gaap	Assets Assets	2292923000	usd
CY2023Q1	us-gaap	Assets Assets	2229783000	usd

Files In Submission

Name	View Source	Status
0001750735-24-000040-index-headers.html	Edgar Link	pending
0001750735-24-000040-index.html	Edgar Link	pending
0001750735-24-000040.txt	Edgar Link	pending
0001750735-24-000040-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrbk-20240331.htm	Edgar Link	pending
mrbk-20240331.xsd	Edgar Link	pending
mrbk-20240331_g1.jpg	Edgar Link	pending
mrbk_ex31x1x3312024.htm	Edgar Link	pending
mrbk_ex31x2x3312024.htm	Edgar Link	pending
mrbk_ex32x3312024.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
mrbk-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mrbk-20240331_def.xml	Edgar Link	unprocessable
mrbk-20240331_lab.xml	Edgar Link	unprocessable
mrbk-20240331_pre.xml	Edgar Link	unprocessable
mrbk-20240331_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRBK
Meridian Corp Stock $mrbk

2024 Q2 Form 10-Q Financial Statement

#000175073524000040 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRBK Meridian Corp Stock $mrbk

2024 Q2 Form 10-Q Financial Statement

#000175073524000040 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRBK
Meridian Corp Stock $mrbk